These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8992495)
1. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. Isenring P; Lebel M; Falardeau P; Grose JH Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):59-63. PubMed ID: 8992495 [TBL] [Abstract][Full Text] [Related]
2. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids. Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476 [TBL] [Abstract][Full Text] [Related]
3. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955 [TBL] [Abstract][Full Text] [Related]
4. Renal eicosanoids and renal hemodynamics in early borderline hypertension. Lebel M; Grose JH Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206 [TBL] [Abstract][Full Text] [Related]
5. Abnormal response of urinary eicosanoid system to norepinephrine infusion in patients with essential hypertension. Uehara Y; Ishimitsu T; Kawabata Y; Matsuoka H; Ishii M; Sugimoto T Prostaglandins Leukot Essent Fatty Acids; 1992 Jun; 46(2):99-104. PubMed ID: 1502257 [TBL] [Abstract][Full Text] [Related]
6. Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Lebel M; Grose JH; Falardeau P Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):41-9. PubMed ID: 2928372 [TBL] [Abstract][Full Text] [Related]
7. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension. Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017 [TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057 [TBL] [Abstract][Full Text] [Related]
9. Reduced excretion of vasodilator prostaglandins in preeclampsia. Minuz P; Covi G; Corsato M; Probitzer P; Spiazzi L; Paluani F; Degan M; Lechi C; Lechi A Agents Actions Suppl; 1987; 22():175-81. PubMed ID: 3324706 [TBL] [Abstract][Full Text] [Related]
10. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. Minuz P; Covi G; Paluani F; Degan M; Lechi C; Corsato M; Lechi A Hypertension; 1988 Jun; 11(6 Pt 1):550-6. PubMed ID: 3290103 [TBL] [Abstract][Full Text] [Related]
11. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690 [TBL] [Abstract][Full Text] [Related]
12. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132 [TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin. Kurki T; Viinikka L; Ylikorkala O Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190 [TBL] [Abstract][Full Text] [Related]
14. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients. Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167 [TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436 [TBL] [Abstract][Full Text] [Related]
17. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. Ylikorkala O; Pekonen F; Viinikka L J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979 [TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243 [TBL] [Abstract][Full Text] [Related]
19. Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. Wennmalm A; Fitzgerald GA Am J Physiol; 1988 Jul; 255(1 Pt 2):H15-8. PubMed ID: 3293469 [TBL] [Abstract][Full Text] [Related]